Conjugated Estrogens and Bazedoxifene Improve β Cell Function in Obese Menopausal Women.
Dragana LovreErin PeacockBonnie KatalenichCynthia MoreauBeibei XuChandra TateKristina M UtzschneiderJean-François GautierVivian FonsecaFranck Mauvais-JarvisPublished in: Journal of the Endocrine Society (2019)
A 12-week treatment of obese postmenopausal women with CEs/BZA improves fasting β cell function and glucose concentrations without change in AIRg, HOMA-IR, DI, body composition, or markers of inflammation.
Keyphrases
- body composition
- bone mineral density
- adipose tissue
- resistance training
- weight loss
- metabolic syndrome
- blood glucose
- type diabetes
- oxidative stress
- polycystic ovary syndrome
- obese patients
- insulin resistance
- breast cancer risk
- postmenopausal women
- photodynamic therapy
- blood pressure
- skeletal muscle
- clinical trial
- escherichia coli
- pseudomonas aeruginosa
- high intensity
- study protocol